Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial
Journal of the American Heart Association · 06.05.2025 · 14 (9)
DOI: 10.1161/jaha.124.038872 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Journal of the American Heart Association, erschienen am 06.05.2025. Verfasst von Henri Lu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine Brigham and Women's Hospital, Harvard Medical School Boston MA USA. Hauptthemen laut MEDLINE: Heart Failure, Malnutrition, Nutrition Assessment, Nutritional Status. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The Controlling Nutritional Status (CONUT) and Geriatric Nutritional Risk Index (GNRI) are indices that identify individuals at risk of malnutrition. Our study sought to examine the incidence and prognostic implications of abnormal CONUT and/or GNRI in patients with heart failure with preserved ejection fraction. Methods and Results The CONUT score and GNRI were serially analyzed in this post hoc analysis of the PARAGON‐HF (Prospective Comparison of Angiotensin Receptor–Neprilysin Inhibitor With Angiotensin‐Receptor Blockers Global Outcomes in Heart Failure With Preserved Ejection Fraction) trial. A CONUT score >2 or GNRI ≤98 was considered to be abnormal. The association between abnormal CONUT and/or GNRI (analyzed using a time‐updated approach) and total heart failure hospitalizations and cardiovascular death was analyzed. Other outcomes included cardiovascular death, all‐cause death, total heart failure hospitalizations, first all‐cause hospitalization, and first noncardiovascular hospitalization. We also explored the effect of incident hospitalization on subsequent incident abnormal CONUT and/or GNRI. In 4794 patients (55% women, mean age 72±8 years), 1119 (23.3%) had at least 1 abnormal score at randomization. Among the remaining 3675 patients, 1405 (38.2%) developed at least 1 abnormal score over a median follow‐up of 2.9 years. Any abnormal score during follow‐up was associated with a significantly higher risk of fatal and nonfatal outcomes, and all types of hospitalizations (all‐cause, heart failure, and noncardiovascular hospitalizations). Among patients with normal scores at randomization, any hospitalization during follow‐up was associated with a significantly higher risk of developing at least 1 abnormal score posthospitalization, compared with prehospitalization and never‐hospitalized patients (adjusted hazard ratio, 1.37 [95% CI, 1.22–1.55]).
Conclusions
Among patients with heart failure with preserved ejection fraction, the rate of individuals with abnormal CONUT and/or GNRI was high, especially following a heart failure hospitalization, and was linked with excess cardiovascular and noncardiovascular events. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01920711.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine Brigham and Women's Hospital, Harvard Medical School Boston MA USA.
- Division of Cardiology Lausanne University Hospital (CHUV), University of Lausanne (UNIL) Lausanne VD Switzerland.
- Department of Cardiovascular Medicine Shinshu University Hospital Matsumoto Nagano Japan.
- Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital, Harvard Medical School Boston MA USA.
- Cardiology Unit, Department of Medical and Surgical Sciences (DIMEC) Alma Mater Studiorum University of Bologna Bologna Italy.
- University of Zagreb School of Medicine, Department of Cardiovascular Diseases University Hospital Center Zagreb Zagreb Croatia.
ORCID-Profile: Henri Lu, Brian L Claggett, John W Ostrominski, Alberto Foà, Maria A Pabón, Arzu Kalayci, Muthiah Vaduganathan, Maja Cikes, Amil M Shah, Akshay S Desai, John J V McMurray, Pardeep S Jhund, Milton Packer, Martin Lefkowitz, Jean L Rouleau, Michael R Zile, Faiez Zannad, Sheila M Hegde, Scott D Solomon, Hicham Skali
Förderung
- NHLBI NIH HHS
Zitieren
APA
Lu, H., Claggett, B. L., Minamisawa, M., Ostrominski, J. W., Foà, A., Pabón, M. A., Kalayci, A., Vaduganathan, M., Cikes, M., Shah, A. M., Desai, A. S., McMurray, J. J. V., Jhund, P. S., Packer, M., Lefkowitz, M., Rouleau, J. L., Zile, M. R., Zannad, F., Hegde, S. M., …, & Skali, H. (2025). Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial. Journal of the American Heart Association, 14(9). https://doi.org/10.1161/jaha.124.038872
Vancouver
Lu H, Claggett BL, Minamisawa M, Ostrominski JW, Foà A, Pabón MA, et al. Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial. Journal of the American Heart Association. 2025;14(9). doi:10.1161/jaha.124.038872
BibTeX
@article{Lu2025,
author = {Lu, Henri and Claggett, Brian L and Minamisawa, Masatoshi and Ostrominski, John W and Foà, Alberto and Pabón, Maria A and Kalayci, Arzu and Vaduganathan, Muthiah and Cikes, Maja and Shah, Amil M and Desai, Akshay S and McMurray, John J V and Jhund, Pardeep S and Packer, Milton and Lefkowitz, Martin and Rouleau, Jean L and Zile, Michael R and Zannad, Faiez and Hegde, Sheila M and Solomon, Scott D and Skali, Hicham},
title = {Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {9},
doi = {10.1161/jaha.124.038872}
}
EUVIMED